Pathogenic variants in actionable MODY genes are associated with type 2 diabetes (2020)
Attributed to:
Targeting GLP-1 receptor trafficking to improve therapies for type 2 diabetes
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s42255-020-00294-3
Publication URI: http://dx.doi.org/10.1038/s42255-020-00294-3
Type: Journal Article/Review
Parent Publication: Nature Metabolism
Issue: 10